ID
38682
Beschrijving
Study ID: 113222 Clinical Study ID: 113222 Study Title: A Phase II, Open Label, Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00920556 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name:5.0g SRT501 Trade Name: Bortezomib Study Indication: Multiple Myeloma
Trefwoorden
Versies (2)
- 04-03-19 04-03-19 -
- 30-10-19 30-10-19 - Sarah Riepenhausen
Houder van rechten
GlaxoSmithKline
Geüploaded op
30 oktober 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma NCT00920556
Cycle 1 Day 20 - PK Sampling - Plasma Samples; SRT501 Administration; Study Treatment Compliance (Return); New Adverse Events and Concomitant Treatment
Beschrijving
Visit Date
Alias
- UMLS CUI-1
- C1320303
Beschrijving
PK Sampling - Plasma Samples
Alias
- UMLS CUI-1
- C0031327
- UMLS CUI-2
- C1277698
- UMLS CUI-3
- C1609077
Beschrijving
Check if Not Applicable
Datatype
integer
Alias
- UMLS CUI [1]
- C1272460
Beschrijving
Time Point
Datatype
integer
Alias
- UMLS CUI [1]
- C2348792
Beschrijving
Date of Sampling
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0870078
Beschrijving
Time of Sampling
Datatype
time
Alias
- UMLS CUI [1,1]
- C0040223
- UMLS CUI [1,2]
- C0870078
Beschrijving
Check if Not Done
Datatype
integer
Alias
- UMLS CUI [1]
- C1272696
Beschrijving
SRT501 Administration
Alias
- UMLS CUI-1
- C0304229
- UMLS CUI-2
- C1320722
Beschrijving
Was SRT501 administered at this visit?
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0304229
- UMLS CUI [1,2]
- C1320722
Beschrijving
Date administered
Datatype
date
Alias
- UMLS CUI [1,1]
- C1521801
- UMLS CUI [1,2]
- C0011008
Beschrijving
Kit #
Datatype
integer
Alias
- UMLS CUI [1]
- C2981406
Beschrijving
Time Administered
Datatype
time
Alias
- UMLS CUI [1,1]
- C1521801
- UMLS CUI [1,2]
- C0040223
Beschrijving
Study Treatment Compliance (Return)
Alias
- UMLS CUI-1
- C1321605
Beschrijving
Check if Not Applicable
Datatype
integer
Alias
- UMLS CUI [1]
- C1272460
Beschrijving
If No, please complete the comments page or the protocol deviations page.
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3890583
- UMLS CUI [1,2]
- C0332156
Beschrijving
If No, please complete the comments page or the protocol deviations page. If No, please provide the number of missed doses and the dates that the doses were missed
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1321605
- UMLS CUI [1,2]
- C0304229
- UMLS CUI [1,3]
- C0178602
Beschrijving
No. of missed dates:
Datatype
integer
Alias
- UMLS CUI [1,1]
- C1705492
- UMLS CUI [1,2]
- C0011008
- UMLS CUI [1,3]
- C0237753
Beschrijving
Dates dose missed:
Datatype
text
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1705492
- UMLS CUI [1,3]
- C0178602
Beschrijving
New Adverse Events and Concomitant Treatment
Alias
- UMLS CUI-1
- C0877248
- UMLS CUI-2
- C2347852
Beschrijving
Check if Not Applicable
Datatype
integer
Alias
- UMLS CUI [1]
- C1272460
Beschrijving
If Yes, please record details on Adverse Events page.
Datatype
boolean
Alias
- UMLS CUI [1]
- C2347852
Beschrijving
If Yes, please record details on Concomitant Treatment page.
Datatype
boolean
Alias
- UMLS CUI [1]
- C2347852
- UMLS CUI [2,1]
- C0678766
- UMLS CUI [2,2]
- C0205217
- UMLS CUI [3,1]
- C0678766
- UMLS CUI [3,2]
- C0205216
- UMLS CUI [4,1]
- C0439603
- UMLS CUI [4,2]
- C0205217
- UMLS CUI [5,1]
- C0439603
- UMLS CUI [5,2]
- C0205216
Similar models
Cycle 1 Day 20 - PK Sampling - Plasma Samples; SRT501 Administration; Study Treatment Compliance (Return); New Adverse Events and Concomitant Treatment
C1277698 (UMLS CUI-2)
C1609077 (UMLS CUI-3)
C0870078 (UMLS CUI [1,2])
C0870078 (UMLS CUI [1,2])
C1320722 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,2])
C0332156 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C0237753 (UMLS CUI [1,3])
C1705492 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
C2347852 (UMLS CUI-2)
C0678766 (UMLS CUI [2,1])
C0205217 (UMLS CUI [2,2])
C0678766 (UMLS CUI [3,1])
C0205216 (UMLS CUI [3,2])
C0439603 (UMLS CUI [4,1])
C0205217 (UMLS CUI [4,2])
C0439603 (UMLS CUI [5,1])
C0205216 (UMLS CUI [5,2])
Geen commentaren